Jazzmyne T. Montgomery, MD, MS

Disclosure information not submitted.

Presentation(s):

• PD24-11: National Trends in Readmissions of Neurogenic Bladder Patients Undergoing Urinary Diversion in the United States 2016-2017: An Analysis Using the National Readmissions Database

  Saturday, May 14, 2022
  11:10 AM – 11:20 AM

• MP54-02: Two-Year Efficacy Follow-Up of a Phase I trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment

  Monday, May 16, 2022
  8:45 AM – 10:00 AM